StartseitevorwärtsAktienvorwärtsActinium PharmaceuticalsvorwärtsNachrichten
    Actinium Pharmaceuticals Aktie
    Aktie
    ISIN: US00507W2061 WKN: A2QA48 SYM: 7AY1 Land Flagge US USA
    Zur Watchlist hinzufügenZur Watchlist hinzufügen Zum Portfolio hinzufügenZum Portfolio hinzufügen
    1,2900
     
    EUR
    +2,54 %
    +0,0320 EUR
    Letzter Kurs 20.06.25 Tradegate

    Actinium Pharmaceuticals Aktie kaufen

    Geldkurs
    20.06.25
    1,2660
     
    EUR
    2.369 STK
    Briefkurs
    20.06.25
    1,3130
     
    EUR
    2.284 STK
    Verkauf
    Kauf
    BEI SMARTBROKER+ HANDELN
    Handeln über unsere
    Partner-Broker
    Brokerize

    Neueste Nachrichten

    ATNM DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important May 27 Deadline in Securities Class Action - ATNM
    27.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
    27.05.25 · Business Wire (engl.) · Actinium PharmaceuticalsEnglische Nachricht
    ATNM DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action - ATNM
    26.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
    26.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
    25.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
    24.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    ATNM IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action - ATNM
    24.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    Tech-Market Report: NASDAQ und TecDAX rutschen ab - Apple (APC) tiefrot
    23.05.25 · Shareribs · AmgenAnzeige
    ATNM Deadline: Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
    23.05.25 · Business Wire (engl.) · Actinium PharmaceuticalsEnglische Nachricht
    ATNM DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 26 Deadline in Securities Class Action - ATNM
    23.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    ATNM DEADLINE ALERT: ROSEN, A LEADING FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 26 Deadline in Securities Class Action - ATNM
    22.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht
    ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
    21.05.25 · newsfile · Actinium PharmaceuticalsEnglische Nachricht